Cancer incidence in municipalities near two former nuclear materials processing facilities in Pennsylvania

Health Physics

Volumn 85, Issue 6, 2003, Pages 678-690

  Boice Jr , John D ^a,d   Bigbee, William L ^b,c   Mumma, Michael T ^a   Blot, William J ^a,d  

^a INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Epidemiology; Health effects; Radiation risk; Uranium

Indexed keywords

PLUTONIUM; RADIOACTIVE MATERIAL; RADIOISOTOPE; URANIUM;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; GEOGRAPHIC DISTRIBUTION; HUMAN; KIDNEY CANCER; LEUKEMIA; LUNG CANCER; NONHODGKIN LYMPHOMA; NUCLEAR PHYSICS; NUCLEAR POWER PLANT; PRIORITY JOURNAL; RADIATION HAZARD; RADIATION RESPONSE; STANDARDIZATION; THYROID CANCER; UNITED STATES; VALIDATION PROCESS;

ADULT; AGED; CITIES; ENVIRONMENTAL EXPOSURE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NUCLEAR REACTORS; OCCUPATIONAL EXPOSURE; PENNSYLVANIA; RISK ASSESSMENT; RISK FACTORS; RURAL POPULATION; TOPOGRAPHY, MEDICAL; URANIUM; URBAN POPULATION;

PARNASSIUS APOLLO;

EID: 0142000326     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004032-200312000-00013     Document Type: Article

References (49)

1. Auvinen A, Kurttio P, Pekkanen J, Pukkala E, Ilus T, Salonen L. Uranium and other natural radionuclides in drinking water and risk of leukemia: a case-cohort study in Finland. Cancer Causes Control 13:825-829; 2002.
2. Bailar JC III, Ederer F. Significance factors for the ratio of a Poisson variable to its expectation. Biometrics 20:639-643; 1964.
3. Boice JD Jr. Study of health effects in areas of high background radiation in China. J Radiol Prot 22:102-104; 2002.
4. Boice JD Jr., Bigbee WL, Mumma MT, Blot WJ. Cancer mortality in populations living near two former nuclear materials processing facilities in Pennsylvania, 1950-1995. Health Phys 85:691-700; 2003.
5. Boice JD Jr., Land CE, Preston DL. Ionizing radiation. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. New York: Oxford University Press; 1996: 319-354.
6. Center for Hazardous Materials Research. Apollo Oversight Project. Pittsburgh, PA: University of Pittsburgh, Applied Research Center; 1994.
7. Code of Federal Regulations. 10 CFR 20. Title 10-Energy. Part 20: Standards for protection against radiation. Available at: http://www.nrc.gov/reading-rm/doc-collections/cfr/part020/. Accessed 19 August 2003
8. Council of the Royal Society. The health hazards of depleted uranium munitions. Part 1. Science Advice Section. London: The Royal Society; 2001.
9. Darby SC, Doll R. Fallout, radiation doses near Dounreay, and childhood leukaemia. Br Med J 294:603-607; 1987.
10. Darby SC, Whitley E, Howe GR, Hutchings SJ, Kusiak RA, Lubin JH, Morrison HI, Tirmarche M, Tomasek L, Radford EP, Roscoe RJ, Samet JM, Shu XY. Radon and cancers other than lung cancer in underground miners: a collaborative analysis of 11 studies. J Natl Cancer Inst 87:378-384; 1995.
11. Doll R. Urban and rural factors in the aetiology of cancer. Int J Cancer 47:803-810; 1991.
12. Doll R, Evans HJ, Darby SC. Paternal exposure not to blame. Nature 367:678-680; 1994.
13. Gilbert ES, Koshumikova NA, Sokolnikov M, Khokhryakov VF, Miller S, Preston DL, Romanov SA, Shilnikova NS, Suslova KG, Vostrotin VV. Liver cancers in Mayak workers. Radiat Res 154:246-252; 2000.
14. Grogan HA, Sinclair WK, Voilleque PG. Risks of fatal cancer from inhalation of 239, 240 plutonium by humans: a combined four-method approach with uncertainty evaluation. Health Phys 80:447-461; 2001.
15. Harley NH, Foulkes EC, Hibome LH, Hudson A, Anthony CR. Depleted uranium: A review of the scientific literature as it pertains to Gulf War illness. Santa Monica, CA: RAND; 1999.
16. Health Canada. Cancer incidence in Port Hope, 1971-1996. Environmental Risk Assessment and Case Surveillance Division Cancer Bureau, Laboratory Centre for Disease Control, Health Canada. Ottawa: Canadian Nuclear Safety Commission; INFO-0716; 2000.
17. Hodge HC, Stannard JN, Hursch JB. Uranium, plutonium, and the transuramic elements. Handbook of experimental pharmacology, Vol. 36. New York: Springer Verlag; 1973.
18. Holowaty EJ, Moravan V, Lee G, Chong N, Dale D. A reabstraction study to estimate the completeness and accuracy of data elements in the Ontario Cancer Registry, Cancer Bureau, Health Canada. Final Report Contract H4078-3-C098. Ottawa: Cancer Bureau, Health Canada; 1996.
19. Institute of Medicine. Committee on the health effects associated with exposures during the Gulf War. Gulf War and health. Volume 1. Depleted uranium, pyridostigmine bromide, sarin, vaccines. Washington, DC: National Academy Press; 2001.
20. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Ionizing radiation, Part 2: Some internally deposited radionuclides. Lyon, France: IARC; Vol 78; 2001.
21. International Commission on Radiological Protection. Age-dependent doses to members of the public from intake of radionuclides. Part 3, Ingestion dose coefficients. Oxford: Pergamon Press; ICRP Publication 69; Annals of the ICRP, Vol. 25, No. 1; 1995a.
22. International Commission on Radiological Protection. Age-dependent doses to members of the public from intake of radionuclides. Part 4, Inhalation dose coefficients. Oxford: Pergamon Press; ICRP Publication 71; Annals of the ICRP, Vol. 25, No. 3-4; 1995b.
23. Jablon S, Hrubec Z, Boice JD Jr. Cancer in populations living near nuclear facilities. A survey of mortality nationwide and incidence in two states. JAMA 265:1403-1408; 1991.
24. Kawachi I, Lochner K. Socioeconomic status. In: Colditz GA, Hunter D, eds. Cancer prevention: The causes and prevention of cancer - Volume I. Netherlands: Kluwer Academic Publishers; 2000: 87-100.
25. Koshumikova NA, Gilbert ES, Sokolnikov M, Khokhryakov VF, Miller S, Preston DL, Romanov SA, Shilnikova NS, Suslova KG, Vostrotin VV. Bone cancers in Mayak workers. Radiat Res 154:237-245; 2000.
26. Kreisheimer M, Koshurnikova NA, Nekolla E, Khokhryakov VF, Romanow SA, Sokolnikov ME, Shilnikova NS, Okatenko PV, Kellerer AM. Lung cancer mortality among male nuclear workers of the Mayak facilities in the former Soviet Union. Radiat Res 154:3-11; 2000.
27. Mao Y, McCourt C, Morrison HI, Pepin-Laplante O, Seminciw R, Silins J, Spasoff R, Trempe N, Wigle D. Community-based mortality surveillance: The Maniwaki experience, Investigation of excess mortality in a community. Can J Pub Health 75:429-433; 1984.
28. Marrett LD, Weir E. Final Report, The accuracy of residence data in the Ontario Cancer Registry: Further Investigations of Frontenac County Data, 1988. Ottawa: Bureau of Chronic Disease Epidemiology, Health and Welfare Canada, Final Report Contract 3557; 1992.
29. McGeoghegan D, Binks K. The mortality and cancer morbidity experience of workers at the Springfields uranium production facility, 1946-95. J Radiol Protect 20:111-137; 2000.
30. National Council on Radiation Protection and Measurements. Recommendations on limits for exposure to ionizing radiation. Bethesda, MD: NCRP; NCRP Report No. 91; 1987.
31. Omar RZ, Barber JA, Smith PG. Cancer mortality and morbidity among plutonium workers at the Sellafield plant of British Nuclear Fuels. Br J Cancer 79:1288-1301; 1999.
32. Pennsylvania Department of Health. Cancer mortality in the Apollo Area of Armstrong and Westmoreland Counties. Harrisburg, PA: Bureau of Epidemiology and Disease Prevention; 1986.
33. Pennsylvania Department of Health. Cancer mortality in the Apollo-Parks area of Armstrong and Westmoreland Counties. Harrisburg, PA: Bureau of Epidemiology and Disease Prevention; 1988a.
34. Pennsylvania Department of Health. Pregnancy outcome study in the Apollo area of Armstrong and Westmoreland Counties. Harrisburg, PA: Bureau of Epidemiology and Disease Prevention; 1988b.
35. Pennsylvania Department of Health. Cancer incidence in the Apollo-Parks areas of Armstrong and Westmoreland Counties during 1984-85. Harrisburg, PA: Bureau of Epidemiology and Disease Prevention; 1989.
36. Pennsylvania Department of Health. Apollo-Parks Cancer Incidence Study 1984-1992. Harrisburg, PA: Bureau of Epidemiology and Disease Prevention; 1996.
37. Pennsylvania Department of Health Pennsylvania cancer incidence and mortality in Pennsylvania 1993-1997. Harrisburg, PA: Bureau of Health Statistics; 2000. Available at: www.health.state.pa.us/stats/. Accessed 19 August 2003.
38. Priest ND. Toxicity of depleted uranium. Lancet 357:244-246; 2001.
39. Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg LX, Edwards BK. SEER Cancer Statistics Review: 1973-1996. National Cancer Institute. NIH Pub. No. 99-2789, 1999. (SEER Stat 3.0. SEER Cancer Incidence Public Use Database, 1973-1997, April 2000).
40. Schiffman MH, Brinton LA, Devesa SS, Fraumeni JF Jr. Cervical cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. New York: Oxford University Press; 1996: 1090-1116.
41. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Izumi S, Preston DL. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat Res 137(Suppl 2):S17-67; 1994.
42. United Nations Scientific Committee on the Effects of Atomic Radiation. UNSCEAR 1994 report to the General Assembly, with Scientific Annexes. Sources and effects of ionizing radiation. E.94.IX11. New York: United Nations; 1994.
43. United Nations Scientific Committee on the Effects of Atomic Radiation. UNSCEAR 2000 report to the General Assembly, with Scientific Annexes. Sources and effects of ionizing radiation. Vol I: Sources, Vol II: Effects. E.00.IX.4. New York: United Nations; 2000.
44. U.S. Bureau of the Census. The American factfinder. Advanced geography selection. 2000. Available at: http://www. census.gov/main/www/access.html. Accessed 19 August 2003.
45. U.S. Department of Commerce. Bureau of the Census. 1990 census of the population. Characteristic of the population. Washington, DC: U.S. Department of Commerce; PC 901-B40; 1992.
46. U.S. Nuclear Regulatory Commission. In the matter of Babcock and Wilcox Company (Pennsylvania Nuclear Service Operations, Parks Township, PA). Docket No. 70-364. Director's decision under 10 C. F. R. 2.206, June 26, 1995. Available at: www.nrc.gov/NRC/Public/2206/Archive/dd-95-12.txt. Accessed 9 July 2001.
47. U.S. Nuclear Regulatory Commission. Removal of the Babcock & Wilcox Apollo Site from the Site Decommissioning Plan. SECY-97-015. January 1997. Available at: www.nrc.gov/reading-rm/doc-collections/commission/secys/1997/secy1997-015scy. html. Accessed 20 August 2003.
48. Voelz GL, Lawrence JN, Johnson ER. Fifty years of plutonium exposure to the Manhattan Project plutonium workers: an update. Health Phys 73:611-619; 1997.
49. Wang Z, Boice JD Jr, Wei L, Beebe GW, Zha Y, Kaplan MM, Tao Z, Maxon HR III, Zhang S, Schneider AB, Tan B, Wesseler TA, Chen D, Ershow AG, Kleinerman RA, Littlefield LG, Preston D. Thyroid nodularity and chromosome aberrations among women in areas of high background radiation in China. J Natl Cancer Inst 82:478-485; 1990.